Cite
HARVARD Citation
Al Draiweesh, S. et al. (n.d.). DOP39 Safety of combination biologic and anti-rejection therapy post-liver transplantation in patients with inflammatory bowel disease: London Ontario experience. Journal of Crohn's and colitis. pp. S048-S049. [Online].